Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …

The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics

AN Hata, JA Engelman, AC Faber - Cancer discovery, 2015 - AACR
The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2
family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic …

Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors

MN Serasinghe, SY Wieder, TT Renault, R Elkholi… - Molecular cell, 2015 - cell.com
Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic
role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic …

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

EF Lee, TJ Harris, S Tran, M Evangelista… - Cell death & …, 2019 - nature.com
Malignant melanoma is one of the most difficult cancers to treat due to its resistance to
chemotherapy. Despite recent successes with BRAF inhibitors and immune checkpoint …

Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer

S D'Aguanno, D Del Bufalo - Cells, 2020 - mdpi.com
The dynamic interplay between pro-death and pro-survival Bcl-2 family proteins is
responsible for a cell's fate. Due to the recognized relevance of this family in cancer …

Physiological and pharmacological control of BAK, BAX, and beyond

MPA Luna-Vargas, JE Chipuk - Trends in cell biology, 2016 - cell.com
Cellular commitment to the mitochondrial pathway of apoptosis is accomplished when
proapoptotic B cell chronic lymphocytic leukemia/lymphoma (BCL)-2 proteins compromise …

Bcl-2 family inhibitors sensitize human cancer models to therapy

E Valentini, M Di Martile, M Brignone, M Di Caprio… - Cell Death & …, 2023 - nature.com
BH3 mimetics, targeting the Bcl-2 family anti-apoptotic proteins, represent a promising
therapeutic opportunity in cancers. ABT-199, the first specific Bcl-2 inhibitor, was approved …

Melatonin enhances autophagy and reduces apoptosis to promote locomotor recovery in spinal cord injury via the PI3K/AKT/mTOR signaling pathway

Y Li, Y Guo, Y Fan, H Tian, K Li, X Mei - Neurochemical research, 2019 - Springer
Spinal cord injury (SCI) leads to neuronal death resulting in central nervous system (CNS)
dysfunction; however, the pathogenesis is still poorly understood. Melatonin (MT), a …

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway

J Zhang, Y Shi, D Hong, M Song, D Huang, C Wang… - Scientific reports, 2015 - nature.com
Accumulating evidences indicate that microRNAs play a vital role in regulating tumor
progression. However, the roles of miR-148b in hepatocellular carcinoma (HCC) are still …

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment

AM Lucianò, M Di Martile, AB Pérez-Oliva… - Journal of Experimental …, 2023 - Springer
Background Macrophages take center stage in the tumor microenvironment, a niche
composed of extracellular matrix and a heterogeneous group of cells, including immune …